抑制Foxo3/Txnip轴通过降低MuRF1的调节来缓解风扇诱导的隔膜功能障碍
1Department of Intensive Care Unit, General Hospital of Ningxia Medical University, No. 804, Shengli South Street, Xingqing District, Yinchuan, 750002, China. shenjia_0711@163.com.
Applied biochemistry and biotechnology
|May 16, 2025
概括
风扇诱导的隔膜功能障碍 (VIDD) 涉及隔膜肌肉的软弱. 抑制Foxo3通路通过减少肌肉缩,炎症和氧化应激来缓解VIDD,提供潜在的治疗标.
科学领域:
- 生理学 生理学 生理学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 呼吸机诱导的隔膜功能障碍 (VIDD) 是从机械通风 (MV) 中断患者的一个重大挑战.
- 转录因子分叉盒O3 (Foxo3) 在骨肌功能中起作用,可能参与VIDD的发病.
研究的目的:
- 调查Foxo3在VIDD发展中的调控作用和潜在机制.
- 为了确定抑制Foxo3是否可以改善VIDD在体外和体内模型.
主要方法:
- 通过使用压力小鼠肌细胞C2C12细胞建立了体外VIDD模型,通过MTT,TUNEL和西方斑点测试评估活力,细胞亡,炎症,氧化应激和蛋白质表达.
- 使用机械通风的体内老鼠模型,给药Foxo3抑制剂Carbenoxolone (CBX) 以评估其对隔膜功能,缩,炎症和氧化应激的影响.
主要成果:
- 在体外,压力损害了肌细胞活力,增加了细胞亡,炎症,氧化压力和活性氧物种 (ROS) 释放,同时激活了Foxo3和Txnip通路.
- 福克索3抑制保护肌细胞细胞从压力诱导的功能障碍,通过Txnip和Murf1.1的下调调节介导的效果.
- 在体内,Foxo3抑制减轻了MV诱导的隔膜缩,减少了炎症和氧化应激,并改善了大鼠的收缩能力.
结论:
- 福克索3的激活通过促进肌细胞亡,炎症和氧化应激,有助于VIDD.
- 抑制Foxo3通过降低Txnip和Murf1等关键通路的调节来缓解VIDD的治疗潜力,从而保持隔膜功能.
相关概念视频
Naturalistic Observations
If you want to understand how behavior occurs, one of the best ways to gain information is to simply observe the behavior in its natural context. However, people might change their behavior in unexpected ways if they know they are being observed. How do researchers obtain accurate information when people tend to hide their natural behavior? As an example, imagine that your professor asks everyone in your class to raise their hand if they always wash their hands after using the restroom. Chances...
Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...


